Telemedicine Expands Access to Trials for Rare Pancreatic Cancer

22 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
0:00 | Introduction
1:00 | Feasibility
1:41 | Role of Academic and Community Oncs
2:50 | Pancreatic Cancer as a Target
4:26 | Addressing Questions With This Trial
6:26 | More Information
7:10 | Next Steps

Improving access to clinical trials remains a constant challenge in developing emerging therapies but a recent trial uses telemedicine to not only complete paperwork and deliver informed consent but also to deliver treatment to patients with a rare type of pancreatic cancer.

Lead investigator Sameek Roychowdhury, MD, professor of medical oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and the Richard J. Solove Research Institute explained what makes this trial unique.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Categoria
Oncology
Commenta per primo questo video.

Prossimo